TapewireFind a company

person · Reporting owner

Keane Robert S

Disclosed activity across 2 companies

Tapewire entity
19737
SEC CIK
0001337084

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
ASTRONICS CORPATRO · Entity 4200DirectorAugust 25, 2026August 26, 2026
CIMPRESS plcCMPR · Entity 4457Director · CEO, ChairmanSeptember 11, 2026September 15, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ASTRONICS CORP

Report date August 25, 2026 · Filed August 26, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
$.01 PV Com StkSEC Table I · non-derivativeIndirectNote76,000 Reported balance After 2026-08-25 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 4 · 2026-08-25 · Conversion · Acquired 76,000 · Balance 76,000

F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026.

F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse

$.01 PV CL B STKSEC Table I · non-derivativeIndirectNote173,838 Reported balance After 2026-08-25 transaction · row 5 Holding and transaction disclosures are not merged.
1 source row

Row 5 · 2026-08-25 · Conversion · Disposed 76,000 · Balance 173,838

F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026.

F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse

$.01 PV CL B STKSEC Table I · non-derivativeIndirectNote248,263 Reported balance Holding disclosure · report date 2026-08-25 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 248,263

F1: Reporting Person is one of multiple potential beneficiaries to the direct owner of these shares, which is a trust (EAK & KRK Trust U/A/D 10-15-97 FBO Elizabeth A. Keane). The entire amount of the trust's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%.

$.01 PV Com StkSEC Table I · non-derivativeDirect13,934 Reported balance Holding disclosure · report date 2026-08-25 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 13,934

$.01 PV CL B STKSEC Table I · non-derivativeDirect2,786 Reported balance Holding disclosure · report date 2026-08-25 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 2,786

Filing footnotes · ownership attribution and instrument terms

F1: Reporting Person is one of multiple potential beneficiaries to the direct owner of these shares, which is a trust (EAK & KRK Trust U/A/D 10-15-97 FBO Elizabeth A. Keane). The entire amount of the trust's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%.

F2: Conversion of 76,000 Class B shares held by Boston & Saranac LLC on August 25, 2026.

F3: The direct owner is Boston & Saranac LLC, a Delaware limited liability company ("Boston & Saranac"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse

CIMPRESS plc

Report date September 11, 2026 · Filed September 15, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary SharesSEC Table I · non-derivativeDirect91,167 Ending reported balance After 2026-09-11 transaction · row 3
3 source rows · reconciled sequence

Row 1 · 2026-09-11 · Sale · Disposed 7,901 · Balance 95,266

F1: Reflects weighted-average sale price (per share prices actually received ranged from $84.17 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Row 2 · 2026-09-11 · Sale · Disposed 3,793 · Balance 91,473

F2: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.96). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Row 3 · 2026-09-11 · Sale · Disposed 306 · Balance 91,167

F3: Reflects weighted-average sale price (per share prices actually received ranged from $86.04 to $86.22). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Ordinary SharesSEC Table I · non-derivativeIndirectBy Second Delaware 2003, LLC769,288 Reported balance After 2026-09-11 transaction · row 4 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 4 · 2026-09-11 · Sale · Disposed 10,712 · Balance 769,288

F4: Reflects weighted-average sale price (per share prices actually received ranged from $84.18 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Ordinary SharesSEC Table I · non-derivativeIndirectBy Second Delaware 2003, LLC764,179 Reported balance After 2026-09-11 transaction · row 5 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 5 · 2026-09-11 · Sale · Disposed 5,109 · Balance 764,179

F5: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Ordinary SharesSEC Table I · non-derivativeIndirectBy Second Delaware 2003, LLC764,000 Reported balance After 2026-09-11 transaction · row 6 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 6 · 2026-09-11 · Sale · Disposed 179 · Balance 764,000

F6: Reflects weighted-average sale price (per share prices actually received ranged from $86.01 to $86.06). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

Ordinary SharesSEC Table I · non-derivativeIndirectBy RHS Delaware Holdings LLC28,375 Reported balance Holding disclosure · report date 2026-09-11 · row 7 Holding and transaction disclosures are not merged.
1 source row

Row 7 · Balance 28,375

Ordinary SharesSEC Table I · non-derivativeIndirectBy Eastern Irrevocable, LLC43,128 Reported balance Holding disclosure · report date 2026-09-11 · row 8 Holding and transaction disclosures are not merged.
1 source row

Row 8 · Balance 43,128

F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners.

Ordinary SharesSEC Table I · non-derivativeIndirectBy Western Irrevocable, LLC47,088 Reported balance Holding disclosure · report date 2026-09-11 · row 9 Holding and transaction disclosures are not merged.
1 source row

Row 9 · Balance 47,088

F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners.

Ordinary SharesSEC Table I · non-derivativeIndirectBy Delaware 2001 Investment Trust51,900 Reported balance Holding disclosure · report date 2026-09-11 · row 10 Holding and transaction disclosures are not merged.
1 source row

Row 10 · Balance 51,900

Ordinary SharesSEC Table I · non-derivativeIndirectBy Third Delaware 2011, LLC986,785 Reported balance Holding disclosure · report date 2026-09-11 · row 11 Holding and transaction disclosures are not merged.
1 source row

Row 11 · Balance 986,785

Filing footnotes · ownership attribution and instrument terms

F1: Reflects weighted-average sale price (per share prices actually received ranged from $84.17 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F2: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.96). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F3: Reflects weighted-average sale price (per share prices actually received ranged from $86.04 to $86.22). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F4: Reflects weighted-average sale price (per share prices actually received ranged from $84.18 to $84.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F5: Reflects weighted-average sale price (per share prices actually received ranged from $85.00 to $85.99). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F6: Reflects weighted-average sale price (per share prices actually received ranged from $86.01 to $86.06). Upon appropriate request, the reporting person will provide information regarding the number of shares sold at each price within the range.

F7: Includes 28,375 shares held by RHS Delaware Holdings LLC, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole owners.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
February 15, 2021 Filed Feb 16, 2021 17:58 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 58,668 $0.00 Strike: $108.31 $0.00
Disclosure

SEC source: 0001262976-21-000012 · wf-form4_161349830337557.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,668

Underlying: Ordinary Shares · 58,668 shares

Expires 2031-02-15

F1 · security: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2020 Equity Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

F2 · derivative.exercise_price: This dollar amount is the 3YMA on the date of grant, which is the baseline against which the CAGR of the 3YMA will be measured.

F1 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2020 Equity Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
November 15, 2020 Filed Nov 17, 2020 14:11 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 1,123 $0.00 Strike: $111.23 $0.00
Disclosure

SEC source: 0001262976-20-000097 · wf-form4_160562225766574.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,123

Underlying: Ordinary Shares · 1,123 shares

Expires 2030-11-15

F1 · security: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each November 24 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

F2 · derivative.exercise_price: This dollar amount is the 3YMA on the date of grant, which is the baseline against which the CAGR of the 3YMA will be measured.

F1 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the compound annual growth rate (CAGR) of the three-year moving average daily price per share of Cimpress' ordinary shares (3YMA). The service-based vesting condition is that 25% of the original number of PSUs vest on each November 24 of 2021 through 2024 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 28, 2020 Filed Aug 31, 2020 20:11 UTC ASTRONICS CORP ATRO · Entity 4200 Exercise / conversionRestricted Stock Unit · Derivative 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048751 · doc4.xml · derivative · entry 8

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: $.01 PV Common Stock · 5,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F5 · derivative.exercise_date: These restricted stock units granted on August 28, 2020.

F5 · derivative.expiration_date: These restricted stock units granted on August 28, 2020.

Read SEC document
August 28, 2020 Filed Aug 31, 2020 20:11 UTC ASTRONICS CORP ATRO · Entity 4200 Exercise / conversion$0.01 PV Common Stock 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048751 · doc4.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 20:44 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 373,827 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 5

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Note

Disclosed balance after: 448,199

F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

F4 · ownership.nature: The direct owner is Boston & Saranac LLC.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 20:44 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 1,409,614 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 4

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Note

Disclosed balance after: 0

F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse.

F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 20:44 UTC ASTRONICS CORP ATRO · Entity 4200 Conversion$0.01 PV Class B Stock 85,695 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 3

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Note

Disclosed balance after: 1,409,614

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Stock is convertible at any time, at the option of the holder, into one fully paid and non-assessable share of Common Stock.

F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 20:44 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Common Stock 85,695 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 2

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Note

Disclosed balance after: 0

F3 · price: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse.

F3 · ownership.nature: As a result of estate planning transactions, 5096 Saranac LLC made an in-kind distribution of the 85,695 shares of Common Stock and 1,409,614 shares of Class B Common Stock held by it to its members, including 373,827 shares of Class B Common Stock to Boston & Saranac. The other shares were distributed in-kind to the Sibling Trusts.

Read SEC document
August 21, 2020 Filed Aug 25, 2020 20:44 UTC ASTRONICS CORP ATRO · Entity 4200 Conversion$0.01 PV Common Stock 85,695 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-048244 · doc4.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · Note

Disclosed balance after: 85,695

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Class B Stock is convertible at any time, at the option of the holder, into one fully paid and non-assessable share of Common Stock.

F2 · ownership.nature: The direct owner is 5096 Saranac LLC, a Delaware limited liability company which was established by a trust of the Reporting Persons father, Kevin T. Keane. As a result of estate planning transactions, the direct owner is now owned 25% by Boston & Saranac LLC, a Delaware limited liability company("Boston & Saranac"), and 75% by limited liability companies owned by trusts for the benefit of the siblings or descendants of siblings of the Reporting Person ("Sibling Trusts"). Boston & Saranac is 100% owned by a trust whose beneficiaries are the Reporting Person and his spouse.

Read SEC document
August 15, 2020 Filed Aug 18, 2020 00:49 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Unit · Derivative 887 $0.00 Strike: $112.72 $0.00
Disclosure

SEC source: 0001262976-20-000061 · wf-form4_159771175137264.xml · derivative · entry 2

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 887

Underlying: Ordinary Shares · 887 shares

Expires 2030-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average of Cimpress' share price (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the PSUs vest on each of September 30, 2020, December 31, 2020, March 31, 2021, and June 30, 2021 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 15, 2020 Filed Aug 18, 2020 00:49 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 14,322 $0.00 Strike: $112.72 $0.00
Disclosure

SEC source: 0001262976-20-000061 · wf-form4_159771175137264.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,322

Underlying: Ordinary Shares · 14,322 shares

Expires 2030-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average of Cimpress' share price (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the PSUs vest on each of September 30, 2020, December 31, 2020, March 31, 2021, and June 30, 2021 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 74,372 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 4

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (2)

Disclosed balance after: 74,372

F2 · ownership.nature: The direct owner is Boston & Saranac.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 297,488 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 3

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (3)

Disclosed balance after: 0

F3 · ownership.nature: As a result of the same estate planning transaction in Note 1 above, 223,116 shares of Class B Stock have been transferred to entities 100% owned by trusts whose beneficiaries are the siblings or the descendants of siblings of the Reporting Person ("Sibling Trusts"). 74,372 shares of Class B Stock have been transferred to Boston & Saranac.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Common Stock 44,726 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 2

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (2)

Disclosed balance after: 44,726

F2 · ownership.nature: The direct owner is Boston & Saranac.

Read SEC document
June 05, 2020 Filed Jun 10, 2020 00:01 UTC Amendment ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Common Stock 178,904 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035415 · doc4a.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (1)

Disclosed balance after: 2,222

F1 · ownership.nature: The direct owner is the Estate of Kevin T. Keane. The Reporting Person is one of multiple beneficiaries to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. Shares held by the estate have been transferred to entities beneficially owned by descendants of Kevin T. Keane in an estate planning transactions. As a result, 134,178 Shares of Common Stock have been transferred to entities of which certain of the Reporting Persons's siblings are the primary beneficiary trusts. 44,726 shares of Common Stock have been transferred to Boston & Saranac LLC, a Delaware limited liability company 100% owned by a trust whose beneficiaries are the Reporting Person and his Spouse ("Boston & Saranac").

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:30 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 74,372 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 4

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (2)

Disclosed balance after: 74,372

F2 · ownership.nature: The direct owner is Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:30 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Class B Stock 297,488 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 3

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (3) & (4)

Disclosed balance after: 1,495,340

F3 · ownership.nature: The direct owner is 5096 Saranac LLC, of which the Estate of Kevin T. Keane, the estate of the deceased father of this form's Reporting Person, was formerly the direct owner. The Reporting Person is one of multiple beneficiaries (and one of multiple trustees) to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%.

F4 · ownership.nature: 25% of the ownership of 5096 Saranac LLC has been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts, and the remaining 75% ownership of 5096 Saranac LLC has been transferred to entities of which certain other of the Reporting Person's siblings are the primary beneficiary trusts. 223,116 shares of Class B Stock have been transferred to entities of which certain of the Reporting Person's siblings are the primary beneficiary trusts. 74,372 shares of Class B Common Stock have been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:30 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Common Stock 44,726 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 2

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (2)

Disclosed balance after: 44,726

F2 · ownership.nature: The direct owner is Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts.

Read SEC document
June 05, 2020 Filed Jun 9, 2020 20:30 UTC ASTRONICS CORP ATRO · Entity 4200 Other$0.01 PV Common Stock 178,904 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-035263 · doc4.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · Note (1)

Disclosed balance after: 2,222

F1 · ownership.nature: The direct owner is the Estate of Kevin T. Keane, the father of this form's Reporting Person. The Reporting Person is one of multiple beneficiaries (and one of multiple trustees) to a trust to be established by that estate. The entire amount of the estate's interest is reported on this form, however the Reporting Person's proportionate interest is below 25%. 134,178 Shares of Common Stock have been transferred to entities of which certain of the Reporting Persons's siblings are the primary beneficiary trusts. 44,726 shares of Common Stock have been transferred to Boston & Saranac LLC, of which the Reporting Person and his spouse are the primary beneficiary trusts.

Read SEC document
February 28, 2020 Filed Mar 2, 2020 21:46 UTC ASTRONICS CORP ATRO · Entity 4200 GrantRestricted Stock Unit · Derivative 5,600 $0.00 $0.00
Disclosure

SEC source: 0001209191-20-014522 · doc4.xml · derivative · entry 15

Keane Robert S · CIK 0001337084 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,600

Underlying: $.01 PV Common Stock · 5,600 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

F4 · derivative.exercise_date: These restricted stock units are scheduled to vest 100% on August 28, 2020.

F4 · derivative.expiration_date: These restricted stock units are scheduled to vest 100% on August 28, 2020.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 112,231 $50.00 Strike: $50.00 $5,611,550.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 20

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 112,231 shares

Expires 2020-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant.

F7 · derivative.exercise_price: $0.0001 added to exercise price solely to differentiate the securities on this Form 4.

F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option.

F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 500,000 $50.00 Strike: $50.00 $25,000,000.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 19

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 500,000 shares

Expires 2020-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant.

F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option.

F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 48,400 $47.91 Strike: $47.91 $2,318,844.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 18

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 48,400 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 500,000 $50.00 Strike: $50.00 $25,000,000.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 17

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Eastern Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 500,000 shares

Expires 2020-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant.

F7 · derivative.exercise_price: $0.0001 added to exercise price solely to differentiate the securities on this Form 4.

F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option.

F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 500,000 $50.00 Strike: $50.00 $25,000,000.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 16

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Eastern Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 500,000 shares

Expires 2020-05-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: The option exercise price per share is $50.00, which is at least 33% higher than the closing price of Cimpress' ordinary shares on the NASDAQ Global Select Market on the date of grant.

F5 · derivative.exercise_date: The share options vest over a seven-year period as follows: 6.25% of the original number of ordinary shares subject to the share options vest on the Exercisable Date in Table II. The remaining ordinary shares vest on a quarterly basis over the subsequent six years in tranches ranging from 1.56% to 10.94% of the original number of ordinary shares subject to the option.

F6 · derivative.exercise_date: In addition to the vesting restrictions referred to in footnote 5 above, these share options are exercisable only on days when the high price per share of Cimpress' ordinary shares on NASDAQ equals or exceeds $75.00.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 48,400 $47.91 Strike: $47.91 $2,318,844.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · derivative · entry 15

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Eastern Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 48,400 shares

Expires 2020-05-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Tax withholdingOrdinary Shares 445,220 $119.91 $53,386,330.20
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 8

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 573,935

F2 · shares: Of the 445,220 shares forfeited, 274,626 shares were forfeited as payment of the exercise price and 170,594 shares were forfeited as payment of the withholding taxes.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 112,231 $50.00 $5,611,550.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 7

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 1,019,155

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 500,000 $50.00 $25,000,000.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 6

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 906,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 48,400 $47.91 $2,318,844.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 5

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 406,924

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Tax withholdingOrdinary Shares 445,220 $119.91 $53,386,330.20
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 4

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 573,975

F2 · shares: Of the 445,220 shares forfeited, 274,626 shares were forfeited as payment of the exercise price and 170,594 shares were forfeited as payment of the withholding taxes.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 112,231 $50.00 $5,611,550.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 3

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 1,019,195

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 500,000 $50.00 $25,000,000.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 2

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 906,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
February 26, 2020 Filed Feb 28, 2020 16:23 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 48,400 $47.91 $2,318,844.00
Disclosure

SEC source: 0001262976-20-000023 · wf-form4_158290700131582.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 406,964

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 28,375 shares held by RHS Holdings Incorporated, of which The Eastern Irrevocable Trust and The Western Irrevocable Trust are the sole shareholders.

Read SEC document
November 15, 2019 Filed Nov 19, 2019 16:43 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 1,119 $0.00 Strike: $111.70 $0.00
Disclosure

SEC source: 0001262976-19-000108 · wf-form4_157418182452292.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,119

Underlying: Ordinary Shares · 1,119 shares

Expires 2029-11-21

F1 · derivative.exercise_price: This dollar amount is the three-year moving average of the daily closing share price of Cimpress' ordinary shares (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F2 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 21 of 2020 through 2023 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date, then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 15, 2019 Filed Aug 19, 2019 20:44 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Unit_ · Derivative 918 $0.00 Strike: $108.92 $0.00
Disclosure

SEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 3

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 918

Underlying: Ordinary Shares · 918 shares

Expires 2029-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F3 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each of September 30, 2019, December 31, 2019, March 31, 2020, and June 30, 2020 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 15, 2019 Filed Aug 19, 2019 20:44 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Unit · Derivative 14,931 $0.00 Strike: $108.92 $0.00
Disclosure

SEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 2

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,931

Underlying: Ordinary Shares · 14,931 shares

Expires 2029-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F3 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each of September 30, 2019, December 31, 2019, March 31, 2020, and June 30, 2020 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 15, 2019 Filed Aug 19, 2019 20:44 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 57,381 $0.00 Strike: $108.92 $0.00
Disclosure

SEC source: 0001262976-19-000076 · wf-form4_156624743877483.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,381

Underlying: Ordinary Shares · 57,381 shares

Expires 2029-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F2 · derivative.exercise_date: Each of these performance share units (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2020 through 2023 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 73,014 $0.00 Strike: $34.25 $0.00
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · derivative · entry 12

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 73,014 shares

Expires 2019-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 73,014 $0.00 Strike: $34.25 $0.00
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · derivative · entry 11

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 0

Underlying: Ordinary Shares · 73,014 shares

Expires 2019-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F3 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Tax withholdingOrdinary Shares 47,220 $89.07 $4,205,885.40
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 4

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 367,024

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 73,014 $34.25 $2,500,729.50
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 3

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Western Irrevocable, LLC

Disclosed balance after: 414,244

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Tax withholdingOrdinary Shares 47,220 $89.07 $4,205,885.40
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 2

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 367,064

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders.

Read SEC document
May 03, 2019 Filed May 6, 2019 17:26 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOrdinary Shares 73,014 $34.25 $2,500,729.50
Disclosure

SEC source: 0001262976-19-000034 · wf-form4_155716358610315.xml · nonDerivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Indirect · By Eastern Irrevocable, LLC

Disclosed balance after: 414,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2018.

F2 · balance_after: Includes 36,875 shares held by RHS Holdings Incorporated, of which Eastern Irrevocable, LLC and Western Irrevocable, LLC are the sole shareholders.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 19:34 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 7,116 $0.00 Strike: $109.35 $0.00
Disclosure

SEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 3

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,116

Underlying: Ordinary Shares · 7,116 shares

Expires 2029-02-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F4 · derivative.exercise_date: Each PSU represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 50% of the original number of PSUs vest on March 31, 2019 and the remaining 50% vest on June 30, 2019 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 19:34 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 1,143 $0.00 Strike: $109.35 $0.00
Disclosure

SEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 2

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,143

Underlying: Ordinary Shares · 1,143 shares

Expires 2029-02-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F3 · derivative.exercise_date: Each PSU represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each November 12 of 2019 through 2022 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
February 15, 2019 Filed Feb 19, 2019 19:34 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 349 $0.00 Strike: $109.35 $0.00
Disclosure

SEC source: 0001262976-19-000024 · wf-form4_155060484749631.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · Director · CEO, Chairman

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349

Underlying: Ordinary Shares · 349 shares

Expires 2029-02-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average (3YMA) on the date of grant, which is the baseline against which the compound annual growth rate (CAGR) of the 3YMA will be measured.

F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 100% of the PSUs vest on June 30, 2019 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on the vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
August 15, 2018 Filed Aug 16, 2018 20:56 UTC CIMPRESS plc CMPR · Entity 4457 GrantPerformance Share Units · Derivative 58,799 $0.00 Strike: $102.68 $0.00
Disclosure

SEC source: 0001262976-18-000064 · wf-form4_153445297518139.xml · derivative · entry 1

Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,799

Underlying: Ordinary Shares · 58,799 shares

Expires 2028-08-15

F1 · derivative.exercise_price: This dollar amount is the three-year moving average daily price per share of Cimpress' ordinary shares ("3YMA") on the date of grant, which is the baseline against which the compound annual growth rate ("CAGR") of the 3YMA will be measured.

F2 · derivative.exercise_date: Each performance share unit (PSU) represents a right to receive between 0 and 2.5 Cimpress ordinary shares upon the satisfaction of both (A) service-based vesting and (B) performance conditions relating to the CAGR of the 3YMA. The service-based vesting condition is that 25% of the original number of PSUs vest on each June 30 of 2019 through 2022 so long as the reporting person continues to be an eligible participant under Cimpress' 2016 Performance Incentive Plan on such vesting date. If the 3YMA CAGR equals or exceeds 11% on any of the sixth through tenth anniversaries of the grant date then the reporting person is entitled to receive a distribution of up to 2.5 Cimpress ordinary shares for each vested PSU on a sliding scale based on the actual CAGR performance.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:36 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 166,659 $0.00 Strike: $34.87 $0.00
Disclosure

SEC source: 0001209191-18-027654 · doc4.xml · derivative · entry 12

Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Western Irrevocable Trust

Disclosed balance after: 0

Underlying: Ordinary Shares · 166,659 shares

Expires 2018-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · kind: Option exercised in full due to expiration on May 2, 2018.

F5 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document
May 01, 2018 Filed May 3, 2018 20:36 UTC CIMPRESS plc CMPR · Entity 4457 Exercise / conversionOption (right to buy) · Derivative 166,659 $0.00 Strike: $34.87 $0.00
Disclosure

SEC source: 0001209191-18-027654 · doc4.xml · derivative · entry 11

Keane Robert S · CIK 0001337084 · CEO, President · Chairman of Management Board

10b5-1 filing: Not disclosed

Ownership: Indirect · By The Eastern Irrevocable Trust

Disclosed balance after: 0

Underlying: Ordinary Shares · 166,659 shares

Expires 2018-05-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on November 27, 2017.

F2 · kind: Option exercised in full due to expiration on May 2, 2018.

F5 · derivative.exercise_date: This option became exercisable as to 25% of the original number of shares on the Exercisable Date shown on Table II, and as to an additional 6.25% of the original number of shares at the end of each successive three-month period thereafter.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.